Dominica Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Dominica Health Times.

Press releases published on June 2, 2026

AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
AB Science : Stonegate Capital Partners actualise sa couverture de l'action AB Science avec un objectif de cours de 4,25 EUR par action
Nutrition Business Journal Releases 2026 Supplement Business Report: U.S. Market Surges Toward $100 Billion Milestone
Update on the Carbios - Wankai project in China
Point d’avancement sur le projet Carbios - Wankai en Chine
NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
OncoBag launches innovative handbag for post-mastectomy women
New Study: Baby Gut Microbiome Differences Linked to Eczema and Food Allergy Emerge by 6 Months
Americans Are Reading The Nutrition Label — And Seeking A Balanced Approach To Front-of-Package Labeling Guidance
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
Oraticx Expands Oral Probiotics Lineup for Daily Oral Care and Oral Microbiome Wellness
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
USOSM Supports OMS Foundation Through 2026 Matching-Gift Incentive
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting
Myriad Genetics Names Raj Jampa as New Chief Technology Officer

Share this page:

Sign up for:

Dominica Health Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.